Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. clinical trial (NCT06284317). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of adding durvalumab after my surgery?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. clinical trial (NCT06284317). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available to me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. clinical trial (NCT06284317). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. clinical trial (NCT06284317). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to visit the clinic for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. clinical trial (NCT06284317). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I do if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. clinical trial (NCT06284317). Contact the study team or your healthcare provider for specific answers.

What this study is about